Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK tech transfer company signs licensing deal for Phase II endocrine product

This article was originally published in Scrip

Executive Summary

Fusion IP, which owns the rights to intellectual property generated at two UK universities – the University of Sheffield and Cardiff University, has signed a licensing deal with a pharmaceutical company utilising IP out of the University of Sheffield. Further details are being withheld for commercial reasons. The licence covers development of a known drug, in the area of certain endocrine diseases, in a market worth over $500 million per annum.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC015574

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel